Screener / SEC EDGAR /CIK 0001393434 /10-K filed Feb 5, 2026, compared with Mar 3, 2025 /Numbers from the XBRL of the 10-Ks
Nasdaq Health care · Pharmaceuticals

Ocular Therapeutix, Inc OCUL

Compare with peers Embed
Insider trades since May 20, 2026

8 insiders sold $1.2M on the market, none bought

Form 4
Bought on the market $0 0 trades
Sold on the market $1.2M 14 trades by 8 insiders
Sold under a 10b5-1 plan 99% of the value sold, under a plan set up in advance
Traded the most Pravin Dugel $407K See Remarks

Open-market buys and sales are the trades an insider chose to make. Grants, option exercises and shares withheld for tax are pay; they show under All.

A year of insider trades, day by day

Open-market buys and sales by officers and directors · Form 4, since Nov 24, 2025

NovDecJanFebMarAprMayJunJulAugSepOctNov Mon Wed Fri

$0 bought on 0 days, $1.2M sold on 7 days. Each square is a day; click one for its Form 4.

SoldBought

Buys and sales by insider

Who traded · Form 4, added up

InsiderBoughtSoldLatest
Pravin Dugel
See Remarks, Director
-$407K Aug 24, 2026
Namrata Saroj
Chief Business Officer
-$232K Nov 5, 2026
Jeffrey S. Heier
Chief Scientific Officer
-$137K Oct 2, 2026
Peter Kaiser
Chief Development Officer
-$127K Oct 2, 2026
Nadia Waheed
Chief Medical Officer
-$123K Jun 3, 2026
Todd Anderman
Chief Legal Officer
-$87K Oct 8, 2026
Sanjay Nayak
Chief Strategy Officer
-$36K Aug 24, 2026
Donald Notman
Chief Operating Officer
-$11K Aug 31, 2026

Owned after: shares held right after the person's latest buy or sale, from the Form 4 the date links to. % of shares: that holding over the shares outstanding on the latest cover page. Only people who bought or sold in this period are listed, and options, restricted units and shares held by others are not counted, so the rows are not a total of what insiders own.

Trade by trade, newest first

Every trade · each date links to its Form 4

Of 14 open-market sales by officers and directors, 1 came in the 30 days before a 10-Q, a 10-K or a results 8-K. Dates only, from the filing index; most companies close the window for insider trades in the weeks before results, so a trade there is often under a 10b5-1 plan.

DateInsiderTypeSharesValue
Nov 5, 2026 Namrata Saroj Sale (10b5-1) -35,370 232K
Oct 8, 2026 Todd Anderman Sale (10b5-1) -11,984 87K
Oct 2, 2026 Jeffrey S. Heier Sale (10b5-1) -10,869 77K
Oct 2, 2026 Peter Kaiser Sale (10b5-1) -9,990 70K
Aug 31, 2026 Donald Notman Sale -1,099 11K
Aug 24, 2026 Pravin Dugel Sale (10b5-1) -21,649 233K
Aug 24, 2026 Jeffrey S. Heier Sale (10b5-1) -3,296 36K
Aug 24, 2026 Sanjay Nayak Sale (10b5-1) -1,897 20K
Aug 24, 2026 Peter Kaiser Sale (10b5-1) -3,035 33K
Jun 3, 2026 Nadia Waheed Sale (10b5-1) -14,828 123K
May 26, 2026 Sanjay Nayak Sale (10b5-1) -1,858 15K
May 26, 2026 Jeffrey S. Heier Sale (10b5-1) -3,018 25K
May 26, 2026 Peter Kaiser Sale (10b5-1) -2,967 24K
May 26, 2026 Pravin Dugel Sale (10b5-1) -21,156 173K

Sources

Form 4s from SEC's filing index. An insider files one within two business days of a trade.

Also

Insider selling plans: the 10b5-1 plans and Form 144 notices behind planned sales.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/OCUL/export.csv") into a cell.

Next:Insider selling plans
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.